20 - 21 February, 2025
GENAP Summit
Munich, Germany
Welcome to the GENAP Summit 2025! This year, we are excited to present a streamlined, single-track format that brings together critical topics in pharmaceutical and biotech innovation, with a primary focus on aseptic production technologies and relevant aspects of GCT. Our unified track will cover essential areas such as aseptic processing, ATMPs, fill/finish processes, Pharma 4.0, robotics, and regulatory considerations.
While the focus remains on aseptic production, we will also explore topics from GCT that intersect with aseptic processing, including analytical development and process strategies. Our sessions will provide valuable insights into regulatory updates, implementation strategies, and best practices to ensure safe and compliant aseptic production. You’ll gain knowledge on environmental monitoring systems, facility cleaning, disinfectant qualification, and cleanroom operations.
Join us in Munich to explore these vital subjects, connect with industry leaders, and gain actionable insights into the future of pharmaceutical and biotech innovation. We look forward to welcoming you to GENAP Summit 2025!
27 - 28 February, 2025
PharmaSynergy-Rx
London, UK
PharmaSynergy is built around one-on-one meetings that connect global pharma BD & Licensing professionals, empowered further by the content-driven program. The event showcases pharma opportunities for internationalization, in/out licensing, investment, and portfolio development.
We are committed to reaching out to the broader BD & L community across the globe and hope that by bringing together like-minded people, we are helping to create connections that are genuinely beneficial to you.
Our partnering events cover the following products:
#PharmaSynergyRx - Rx, Niche generics, VAMs, Biosimilars, Orphan, Specialty products and NCEs.
#PharmaSynergyOTC - OTC & CHC products.
3rd - 6th March, 2025
15th World ADC London
London, UK
Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has seen a surge in multi-billion-dollar acquisitions, commercialisation deals, and licensing agreements. These developments have enabled the ADC community to make strides in bringing these therapies to earlier-line treatments and expand their use to wider patient populations.
Returning for its 15th anniversary year, World ADC London is the leading European conference uniting over 1000 ADC enthusiasts to maximise the therapeutic index of ADCs. Whether you are brand new to the field or have over a decade of experience, work in discovery or manufacturing, hold a strategic position or work day-to-day in the lab, this meeting offers something for you!
Don’t miss this chance to unlock unmissable R&D, focused industry networking opportunities, and emerging trends taking hold of the ADC field with sessions from 120+ world-leading speakers including Daiichi Sankyo, AstraZeneca, Pfizer, AbbVie, Merck, GSK, Johnson & Johnson, ADC Therapeutics and more.
4 - 6 March 2025
RNA Leaders Europe
Basel, Switzerland
The RNA Leaders program features scientific tracks covering in-depth development strategies, trends and technologies across the entire long and small RNA spectrum.
10 - 11 March, 2025
euroPLX 87 Vienna
Vienne, Autria
This 87th Marketplace is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices.
17 - 20 March 2025
DCAT Week
New York, NY, USA
DCAT Week is the premier global event held each year in New York City for companies engaged in the Bio/Pharmaceutical manufacturing value chain.
DCAT Week is not a Trade Show. It is a multifaceted event where Member Companies have the opportunity to reserve meeting space through the DCAT organization to conduct high-level, private, strategic meetings with customers and suppliers. During the week, DCAT offers its members the chance to participate in unique and timely education sessions developed by their colleagues who serve on DCAT’s volunteer committees and task forces. Additionally, members can attend various networking events, access member lounges, and take advantage of other opportunities designed to promote interaction between industry colleagues.
17 - 19 March, 2025
BioEurope Spring
Milan, Italy
BIO-Europe Spring connects Europe’s top innovation centers with the global life sciences industry to cultivate thriving strategic partnerships
partneringONETM, the gold standard platform, is more than just a partnering system. partneringONE is an online conference platform that allows delegates to contact other participants and schedule meetings with them. It can also be used as a simple networking and messaging tool.
25 - 26 March, 2025
PDA Parenteral Packaging Conference 2025
Malaga, Spain
15 Years of Innovation in Parenteral Packaging – What Will the Next 15 Bring?
On behalf of the PDA and the Scientific Program Planning Committee, it is our pleasure to welcome you to this year’s 15th-anniversary edition of the PDA Parenteral Packaging Conference, taking place in the beautiful city of Malaga, Spain, from 25 to 26 March 2025. This milestone event brings us together to address the most pressing challenges and innovations shaping our field. Over the past 15 years, the landscape of parenteral packaging has evolved significantly, reflecting both the ingenuity and adaptability of our industry.
This year’s conference represents a unique platform for advancing our understanding, sharing expertise, and fostering collaboration in areas crucial to patient safety and product efficacy. Alongside our timely agenda topics—including PFAS regulations, Container Closure Integrity Testing (CCIT), sustainability initiatives, and innovative packaging solutions—we will reflect on the transformative changes that have shaped our field over the last decade and a half.
The evolution of prefilled syringes, for instance, has revolutionized drug delivery, offering unparalleled precision and convenience. Similarly, the advent of advanced materials like polymers has expanded possibilities for safer, more versatile packaging. Automation and traceability—increasingly powered by AI technologies—are reshaping manufacturing and quality assurance processes. The COVID-19 pandemic has been a pivotal force, emphasizing the need for agility and resilience across the supply chain. And ongoing regulatory changes have continuously guided us toward greater compliance, safety, and innovation.
In addition to these discussions, the plenary and parallel sessions will delve deeply into sterilization and cold chain solutions, each vital to ensuring the quality and reliability of packaged products. A rich lineup of presentations awaits, complemented by ample opportunities for networking during coffee and lunch breaks. And don’t miss our networking party, a chance to connect in a more informal setting, and be sure to explore the technical posters showcasing innovative research and projects from leading experts.
As the demand for safer, more sustainable, and efficient packaging solutions grows, our collective efforts remain pivotal. We are confident that the insights gained during this 15th edition will not only inform current practices but also drive meaningful progress for years to come.
25 - 27 March, 2025
4th Novel Conjugate Summit
Boston, MA, USA
Pioneering Bioconjugates With Novel Payloads & Targeting Formats
We are witnessing a surging 83% growth of novel drug conjugates, with major collaborations between Nurix & Pfizer for antibody-degrader conjugates and Bicycle & Novartis for radiopharmaceuticals. With investments booming in bispecific ADCs, peptide drug conjugates and oligonucleotide conjugates, the charge is on to make iterative and incremental improvements to ADCs to pave the way towards a new generation of more targeted, safer and efficacious novel conjugated drugs.
Encompassing the landscape of these new frontiers in targeted cancer therapy, the 4th Novel Conjugates Summit is returning as a one-stop shop to shine a spotlight on which novel approaches are currently being explored, what benefit each approach has, and provide a comprehensive assessment on how you can widen your conjugate design toolkit.
Join us next March to find the next hottest conjugate approach as we delve into emerging data and industry-leading discussions around novel bioconjugate design and development to redefine the future of targeted cancer therapies.
